| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
50,216 |
44,840 |
$3.52M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
69,979 |
63,588 |
$3.26M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
79,414 |
70,248 |
$3.11M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
30,328 |
27,821 |
$2.32M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
29,943 |
26,830 |
$2.24M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
21,570 |
18,916 |
$1.79M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
25,391 |
22,516 |
$1.70M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
16,289 |
7,116 |
$1.20M |
| 92552 |
|
67,513 |
59,985 |
$1.11M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
68,818 |
60,136 |
$535K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15,630 |
13,989 |
$528K |
| 99173 |
|
67,534 |
60,044 |
$401K |
| 96127 |
|
52,200 |
44,608 |
$290K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,932 |
7,875 |
$274K |
| 99401 |
|
10,065 |
8,137 |
$235K |
| 96160 |
|
11,343 |
10,106 |
$214K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,451 |
8,650 |
$193K |
| 99381 |
|
2,354 |
1,980 |
$175K |
| 96161 |
|
20,441 |
17,398 |
$160K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,287 |
3,607 |
$132K |
| 36416 |
|
69,664 |
60,866 |
$124K |
| 87428 |
|
2,328 |
2,244 |
$120K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,403 |
2,268 |
$114K |
| 90651 |
|
12,855 |
11,074 |
$77K |
| 81003 |
|
38,559 |
34,146 |
$76K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,129 |
4,895 |
$67K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,944 |
3,326 |
$60K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,059 |
4,673 |
$56K |
| 0071A |
|
1,315 |
1,162 |
$50K |
| 92522 |
|
2,586 |
2,310 |
$42K |
| 3008F |
|
74,724 |
66,602 |
$40K |
| 90734 |
|
5,900 |
5,087 |
$38K |
| 92567 |
|
2,255 |
1,885 |
$35K |
| 0072A |
|
919 |
875 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,363 |
1,118 |
$30K |
| 0001A |
|
793 |
734 |
$29K |
| 87631 |
|
643 |
596 |
$26K |
| 0002A |
|
660 |
618 |
$24K |
| 99383 |
|
281 |
247 |
$24K |
| 0081A |
|
499 |
379 |
$19K |
| 90710 |
|
7,869 |
7,133 |
$17K |
| 90670 |
|
19,570 |
17,724 |
$17K |
| 0054A |
|
319 |
267 |
$11K |
| 69210 |
|
478 |
327 |
$10K |
| 0082A |
|
258 |
217 |
$10K |
| 90715 |
|
4,142 |
3,473 |
$8K |
| 99382 |
|
80 |
79 |
$7K |
| 81001 |
|
2,752 |
2,331 |
$7K |
| 90619 |
|
3,683 |
2,931 |
$7K |
| 90633 |
|
12,973 |
11,883 |
$6K |
| 90686 |
|
23,898 |
21,979 |
$6K |
| 90621 |
|
1,476 |
1,274 |
$6K |
| 90716 |
|
2,968 |
2,726 |
$6K |
| 0124A |
|
149 |
132 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
2,428 |
2,173 |
$5K |
| 90696 |
|
3,145 |
2,809 |
$5K |
| 90680 |
|
14,081 |
12,684 |
$5K |
| 0154A |
|
120 |
114 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,276 |
2,121 |
$5K |
| 99384 |
|
45 |
40 |
$4K |
| 90688 |
|
7,740 |
6,871 |
$4K |
| 0052A |
|
111 |
106 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
53 |
44 |
$4K |
| 90677 |
|
3,244 |
3,026 |
$4K |
| 90480 |
|
98 |
94 |
$4K |
| 90697 |
|
6,022 |
5,634 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
257 |
244 |
$3K |
| 90707 |
|
2,943 |
2,707 |
$2K |
| 96380 |
|
114 |
100 |
$2K |
| 90723 |
|
5,407 |
4,724 |
$2K |
| 94760 |
|
2,003 |
1,712 |
$2K |
| 90698 |
|
5,304 |
4,885 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
19 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
97 |
81 |
$1K |
| 0051A |
|
31 |
25 |
$1K |
| 0173A |
|
28 |
24 |
$1K |
| 87634 |
|
51 |
42 |
$1K |
| 90648 |
|
8,076 |
7,090 |
$898.76 |
| 99462 |
|
35 |
24 |
$817.22 |
| 94200 |
|
60 |
49 |
$735.00 |
| 71046 |
Radiologic examination, chest; 2 views |
32 |
25 |
$646.89 |
| 90656 |
|
1,932 |
1,890 |
$634.05 |
| 90380 |
|
63 |
55 |
$600.00 |
| 94250 |
|
46 |
39 |
$589.35 |
| 85027 |
|
5,289 |
5,070 |
$564.51 |
| 0074A |
|
14 |
12 |
$553.44 |
| 90700 |
|
1,596 |
1,437 |
$548.20 |
| 94664 |
|
118 |
107 |
$430.27 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
34 |
27 |
$330.54 |
| 90623 |
|
174 |
161 |
$276.00 |
| 90473 |
|
19 |
17 |
$226.30 |
| 81025 |
|
46 |
38 |
$209.97 |
| 90744 |
|
1,218 |
1,138 |
$122.74 |
| 87420 |
|
30 |
26 |
$100.83 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
12 |
$47.30 |
| 69209 |
|
20 |
13 |
$15.29 |
| 99080 |
|
1,742 |
1,507 |
$14.00 |
| 99000 |
|
17,536 |
15,797 |
$8.61 |
| J7510 |
Prednisolone oral, per 5 mg |
47 |
42 |
$6.33 |
| 99072 |
|
39,212 |
35,546 |
$1.88 |
| 91307 |
|
2,742 |
2,439 |
$0.00 |
| 91305 |
|
994 |
858 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,923 |
1,586 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
465 |
388 |
$0.00 |
| 90674 |
|
366 |
343 |
$0.00 |
| 91315 |
|
146 |
138 |
$0.00 |
| 90381 |
|
15 |
14 |
$0.00 |
| 91317 |
|
56 |
52 |
$0.00 |
| 30999 |
|
30 |
28 |
$0.00 |
| 90687 |
|
215 |
207 |
$0.00 |
| 91308 |
|
1,030 |
819 |
$0.00 |
| 91300 |
|
1,695 |
1,562 |
$0.00 |
| 90661 |
|
268 |
185 |
$0.00 |
| 87400 |
|
62 |
28 |
$0.00 |
| 90685 |
|
627 |
607 |
$0.00 |
| 91312 |
|
196 |
177 |
$0.00 |